Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the "CFO") of Oramed Pharmaceuticals Inc. (the "Company"), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024. The Company has initiated a search process to appoint a new CFO.

Attachments

  • Original Link
  • Permalink

Disclaimer

Oramed Pharmaceuticals Inc. published this content on 13 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 May 2024 10:04:10 UTC.